Central European governments reduce pharmaceutical spending

Several Central European countries are changing their policies on pharmaceutical reimbursements, which may have far reaching effects, especially in the […]

Legislative changes to hamper innovative drugs market in Central Europe between 2012 and 2014

Due to legislative changes implemented during 2011 in most of the Central European (CE) countries, the innovative drug market in […]